Literature DB >> 6403794

Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content.

A G Chapman, B S Meldrum, E Mendes.   

Abstract

Ten analogues of valproic acid (substituted butyric, pentanoic and hexanoic acids) were tested for anticonvulsant activity against audiogenic seizures in DBA/2 mice. There is a consistent correlation between the structure of these branched-chain fatty acids and their anticonvulsant potency, the larger molecules being the more active. There is also a strong correlation between the anticonvulsant potency of these compounds and their ability to reduce cerebral aspartate levels. Cerebral GABA levels are elevated by most, but not all, of the actively anticonvulsant valproate analogues.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403794     DOI: 10.1016/0024-3205(83)90054-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  9 in total

Review 1.  Antiepileptic drug treatment in the nineties in The Netherlands.

Authors:  D G Kasteleijn-Nolstlt Trenité; P M Edelbroek
Journal:  Pharm World Sci       Date:  1997-04

2.  Anaesthesia abolishes the effect of valproate on extracellular 5-HIAA, DOPAC and ascorbate as measured in rat striatum by differential pulse voltammetry.

Authors:  F Crespi; P E Keane; M Morre
Journal:  Br J Pharmacol       Date:  1986-01       Impact factor: 8.739

3.  Anticonvulsant effects of some calcium entry blockers in DBA/2 mice.

Authors:  G B De Sarro; B S Meldrum; G Nisticó
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

4.  Inhibition of quisqualate-induced seizures by glutamic acid diethyl ester and anti-epileptic drugs.

Authors:  S S Schwarz; W J Freed
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Aspartic acid aminotransferase activity is increased in actively spiking compared with non-spiking human epileptic cortex.

Authors:  S J Kish; L M Dixon; A L Sherwin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-04       Impact factor: 10.154

Review 6.  Differentiation between valproate-induced anticonvulsant effect, teratogenicity and hepatotoxicity. Aspects of species variation, pharmacokinetics, metabolism and implications of structural specificity for the development of alternative antiepileptic agents such as delta 2-valproate.

Authors:  H Nau; H Siemes
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

7.  The antiepileptic drug valproic acid and other medium-chain fatty acids acutely reduce phosphoinositide levels independently of inositol in Dictyostelium.

Authors:  Pishan Chang; Benoit Orabi; Rania M Deranieh; Manik Dham; Oliver Hoeller; Jakob A Shimshoni; Boris Yagen; Meir Bialer; Miriam L Greenberg; Matthew C Walker; Robin S B Williams
Journal:  Dis Model Mech       Date:  2011-08-29       Impact factor: 5.758

Review 8.  Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile.

Authors:  Manish Kumar Mishra; Samiksha Kukal; Priyanka Rani Paul; Shivangi Bora; Anju Singh; Shrikant Kukreti; Luciano Saso; Karthikeyan Muthusamy; Yasha Hasija; Ritushree Kukreti
Journal:  Molecules       Date:  2021-12-24       Impact factor: 4.411

9.  Anticonvulsant effects of iridoid glycosides fraction purified from Feretia apodanthera Del. (Rubiaceae) in experimental mice models of generalized tonic-clonic seizures.

Authors:  Germain Sotoing Taiwe; Bernard Dabole; Thierry Bang Tchoya; Joseph Renaud Menanga; Paul Désiré Djomeni Dzeufiet; Michel De Waard
Journal:  BMC Complement Altern Med       Date:  2016-08-12       Impact factor: 3.659

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.